Long-Term Outcomes & Durability of Effect Following Treatment With

Clinical Trial Summary

The objective of this study was to collect data both retrospectively and prospectively in order to evaluate the long-term outcomes, durability of effect, and real-world treatment patterns following treatment with Cladribine Tablets or placebo in participants with multiple sclerosis (MS) who were previously participated in the parent studies (ORACLE MS and CLARITY/CLARITY-EXT).

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05177523` - Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis
Not yet recruiting	`NCT06053749` - An Observational Study to Learn About the Interferon-beta Exposure of Pregnant Women During the Second and Third Trimester in Finland and Sweden
Not yet recruiting	`NCT06450600` - Enhancing Quality of Life in MS Patients Through Tailored Therapeutic Education	N/A
Recruiting	`NCT04926818` - Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis	Phase 3
Not yet recruiting	`NCT03624296` - Characterization of Cortical Injury in Early MS Patients: a 7T MRI Study	N/A
Terminated	`NCT04203498` - Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis	Phase 3
Active, not recruiting	`NCT04602390` - Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis	Phase 1
Completed	`NCT01804647` - Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease
Terminated	`NCT04907305` - Next-Gen MS: Feed-forward PRO Data for MS Research
Active, not recruiting	`NCT03456206` - Chronic Inflammatory Disease, Lifestyle and Risk of Disease
Completed	`NCT04705610` - Social Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculography	N/A
Completed	`NCT01366027` - PRISM Registry: Pseudobulbar Affect Registry Series	N/A
Completed	`NCT03135249` - Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis	Phase 4
Recruiting	`NCT05633875` - Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple Sclerosis
Completed	`NCT02612935` - An Observational Pilot Study of Lumosity Computerized Cognitive Training in Subjects With Multiple Sclerosis	N/A
Completed	`NCT02739542` - Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)	Phase 4
Completed	`NCT03177655` - Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis	N/A
Active, not recruiting	`NCT04777539` - Comparing the Safety and Benefit of Natalizumab (Tysabri®) At-home Infusion vs At-hospital Infusion in Multiple Sclerosis
Recruiting	`NCT02352194` - Physical Capacity and Rehabilitation of Patients With Multiple Sclerosis	N/A
Completed	`NCT02308579` - Centralized Reading Assessment of Chronic CerebroSpinal Venous Insufficiency (CCSVI) in Patients With Multiple Sclerosis and Other Neurological Diseases	N/A

NCT number	NCT03961204
Study type	Interventional
Source	EMD Serono
Contact
Status	Completed
Phase	Phase 4
Start date	August 15, 2019
Completion date	May 13, 2021

Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS (CLASSIC-MS)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms